Gilead’s remdesivir receives first FDA approval as Covid-19 drug
Antiviral remdesivir was one of the drugs used to treat US President Donald Trump
23 October 2020 - 00:07
New York — The US Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients with Covid-19 in hospital, making it the first and only drug approved for the disease in the US.
Remdesivir, given intravenously, was one of the drugs used to treat US President Donald Trump during his bout with Covid-19...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.